--- title: "丰倍生物 (603334.SH) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/603334.SH/norm.md" symbol: "603334.SH" name: "丰倍生物" parent: "https://longbridge.com/zh-CN/quote/603334.SH.md" datetime: "2026-05-21T05:49:44.192Z" locales: - [en](https://longbridge.com/en/quote/603334.SH/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/603334.SH/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/603334.SH/norm.md) --- # 丰倍生物 (603334.SH) — 财务报表 ## 利润表 (CNY) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | 0.2800 | 0.1781 | 0.3358 | 0.3700 | 0.3400 | | ROE | 9.51% | 7.23% | - | 20.20% | 19.41% | | 营业收入 | 1.11B | 919.39M | 773.28M | 739.06M | 665.69M | | 净利润 | 40.88M | 23.26M | 32.24M | 42.53M | 36.67M | | 营业利润 | 49.29M | 24.41M | 37.86M | 47.61M | 40.29M | | 毛利率 | 6.02% | 5.80% | 8.18% | 9.45% | 9.98% | | 净利率 | 3.69% | 2.53% | 4.17% | 5.75% | 5.51% | | 利润含金量 | 89.05% | 22.96% | -30.22% | -1273.05% | -67.45% | ## 资产负债表 (CNY) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 2.17B | 2.23B | 1.44B | 1.38B | - | | 权益乘数 | 1.24 | 1.31 | 1.64 | 1.64 | - | | 每股净资产 | 12.12 | 11.83 | 8.13 | 7.83 | 7.02 | | 资产周转率 | - | 1.83 | - | - | - | | 现金及短投 | 792.58M | 867.30M | 106.03M | 202.10M | 166.78M | | 存货与应收 | 453.66M | 522.60M | 368.41M | 255.01M | - | | 长期投资 | 414.47M | 416.88M | 424.54M | 429.43M | - | | 净债务 | -668.06M | -615.52M | 265.80M | 146.55M | 126.83M | ## 现金流量表 (CNY) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | 55.35M | 106.31M | -125.27M | -3.74M | -59.73M | | 投资现金流 | 160.06M | -303.17M | -5.03M | -7.54M | -6.64M | | 融资现金流 | -111.34M | 664.81M | 30.75M | 25.32M | 21.48M | | 自由现金流 | 29.73M | 101.17M | - | 29.81M | - | | 现金流充裕率 | 38.82% | 39.91% | -397.80% | -4.25% | -52.36% | | 举债与偿债 | 20.50M | 145.61M | 43.02M | 105.74M | 129.50M | | 资本支出 | -10.74M | -5.81M | -3.56M | -7.50M | -6.64M | ## 分红方案 **股息率**: 0.78